About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01535118

A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)

This study will gather information on allergic rhinoconjunctivitis from surveys completed by adults and children.

Lead sponsor: ALK-Abelló A/S•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

ALK-Abelló A/S

Age

5 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Diagnosed with hay fever, rhinitis or nasal and/or eye allergies and display symptoms of sneezing, itching, watery eyes, nasal congestion, or other nasal or eye allergy symptoms over the past 12 months OR take any medication for their hay fever, rhinitis, nasal or eye allergies
•5 years of age or older
•Have a telephone

Exclusion Criteria

•If less than 18 years old and there is no adult available that is knowledgeable about the participant's health

Related studies

RECRUITINGPhase 4

Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study

NCT06778213 · Allergic Rhinoconjunctivitis

COMPLETEDPhase 2

Study of BLU-808 in Allergic Rhinoconjunctivitis

NCT06922448 · Allergic Rhinoconjunctivitis

COMPLETEDPhase 2

Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction

NCT04502966 · Allergic Rhinoconjunctivitis, Grass Pollen Allergy

TERMINATEDPhase 3

Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis

NCT04874714 · Allergic Rhinoconjunctivitis, Perennial Allergic Rhinitis, and more

Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients

NCT03850626 · Allergic Rhinoconjunctivitis, Allergic Asthma

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 3, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment2,765

Start dateJan 2012

Last updatedMar 3, 2017

Condition

Allergic Rhinoconjunctivitis

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 3, 2017Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions